PNC Financial Services Group
ABOS icon

PNC Financial Services Group’s Acumen Pharmaceuticals ABOS Stock Holding History

PNC Financial Services Group’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.27K Hold
3,080
– – ﹤0.01% 4093
2025
Q4 		$6.5K Hold
3,080
– – ﹤0.01% 4129
2025
Q3 		$5.27K Sell
3,080
-1,868
-38% -$2.58K ﹤0.01% 4182
2025
Q2 		$5.74K Buy
4,948
+502
+11% +$540 ﹤0.01% 4079
2025
Q1 		$4.89K Buy
+4,446
New +$6.35K ﹤0.01% 4073

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

PNC Financial Services Group's ABOS Position: Q1 2026 in Review

PNC Financial Services Group held its Acumen Pharmaceuticals (ABOS) position steady in Q1 2026 at 3,080 shares worth $7.27K. The position accounts for ﹤0.01% of the portfolio, ranked #4093.

PNC Financial Services Group first reported a position in ABOS in Q1 2025 and has held it in 5 quarters since. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • PNC Financial Services Group held 3,080 shares of Acumen Pharmaceuticals worth $7.27K as of Q1 2026.
  • PNC Financial Services Group left its Acumen Pharmaceuticals share count unchanged in Q1 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4093 holding.
  • PNC Financial Services Group first reported a position in Acumen Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.